Progression-free survival as a surrogate endpoint for overall survival in patients with relapsed or refractory multiple myeloma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Progression-free survival as a surrogate endpoint for overall survival in patients with relapsed or refractory multiple myeloma ; volume:24 ; number:1 ; day:29 ; month:4 ; year:2024 ; pages:1-7 ; date:12.2024
BMC cancer ; 24, Heft 1 (29.4.2024), 1-7, 12.2024
- Creator
-
Dimopoulos, Meletios
Sonneveld, Pieter
Manier, Salomon
Lam, Annette
Roccia, Tito
Schecter, Jordan M.
Cost, Patricia
Pacaud, Lida
Poirier, Abbey
Tremblay, Gabriel
Lan, Tommy
Valluri, Satish
Kumar, Shaji
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-024-12263-0
- URN
-
urn:nbn:de:101:1-2407112123293.264556973825
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dimopoulos, Meletios
- Sonneveld, Pieter
- Manier, Salomon
- Lam, Annette
- Roccia, Tito
- Schecter, Jordan M.
- Cost, Patricia
- Pacaud, Lida
- Poirier, Abbey
- Tremblay, Gabriel
- Lan, Tommy
- Valluri, Satish
- Kumar, Shaji
- SpringerLink (Online service)
Other Objects (12)
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm
Identification on surrogating overall survival with progression-free survival of first-line immunochemotherapy in advanced esophageal squamous cell carcinoma—an exploration of surrogate endpoint
Progression-free or overall survival…revisited in BOLERO-2
Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials
Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma
Venetoclax ex vivo functional profiling predicts improved progression-free survival
Excellent survival in relapsed stage I testicular cancer
Surrogate threshold effect based on a meta-analysis for the predictive value of progression-free survival for overall survival in hormone receptor-positive, HER2-negative metastatic breast cancer
A novel DNA methylation signature to improve survival prediction of progression-free survival for testicular germ cell tumors
Progression-free survival, prognostic factors, and surgical outcome of spheno-orbital meningiomas
Estimating progression-free survival in patients with glioblastoma using routinely collected data
Potential prognostic factors in progression-free survival for patients with cervical cancer
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm
Identification on surrogating overall survival with progression-free survival of first-line immunochemotherapy in advanced esophageal squamous cell carcinoma—an exploration of surrogate endpoint
Progression-free or overall survival…revisited in BOLERO-2
Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials
Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma
Venetoclax ex vivo functional profiling predicts improved progression-free survival
Excellent survival in relapsed stage I testicular cancer
Surrogate threshold effect based on a meta-analysis for the predictive value of progression-free survival for overall survival in hormone receptor-positive, HER2-negative metastatic breast cancer
A novel DNA methylation signature to improve survival prediction of progression-free survival for testicular germ cell tumors
Progression-free survival, prognostic factors, and surgical outcome of spheno-orbital meningiomas
Estimating progression-free survival in patients with glioblastoma using routinely collected data
Potential prognostic factors in progression-free survival for patients with cervical cancer
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm
Identification on surrogating overall survival with progression-free survival of first-line immunochemotherapy in advanced esophageal squamous cell carcinoma—an exploration of surrogate endpoint
Progression-free or overall survival…revisited in BOLERO-2
Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials
Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma
Venetoclax ex vivo functional profiling predicts improved progression-free survival
Excellent survival in relapsed stage I testicular cancer
Surrogate threshold effect based on a meta-analysis for the predictive value of progression-free survival for overall survival in hormone receptor-positive, HER2-negative metastatic breast cancer
A novel DNA methylation signature to improve survival prediction of progression-free survival for testicular germ cell tumors
Progression-free survival, prognostic factors, and surgical outcome of spheno-orbital meningiomas
Estimating progression-free survival in patients with glioblastoma using routinely collected data